With the exception of HOXB5, higher promoter methylation frequencies were found among tumours from patients with relatively early FIGO stages (I-II) than late stages, but reached statistical significance only for HOXA9 and SCGB3A1 (P = 0.002, P = 0.020, respectively). This evidence concerns the gene HOXA9 and neoplasm.